Hans-Dirk Düngen Selected Research

Bisoprolol (Concor)

2/2016	Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
1/2014	Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD).
6/2013	Determinants of change in quality of life in the Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD).
2/2013	Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis.
11/2012	Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly.
6/2011	Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.
9/2008	Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans-Dirk Düngen Research Topics

Disease

43	Heart Failure 10/2023 - 09/2008
4	Atrial Fibrillation 04/2019 - 01/2009
3	Cardiomyopathies (Cardiomyopathy) 05/2024 - 12/2011
2	Hypertension (High Blood Pressure) 01/2021 - 01/2009
2	Heart Diseases (Heart Disease) 10/2019 - 12/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 12/2014
2	Diastolic Heart Failure 01/2018 - 02/2013
1	Angina Pectoris 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 03/2021
1	Leukemia 03/2021
1	Lymphoma (Lymphomas) 03/2021
1	Hyperkalemia 10/2019
1	Hypotension (Low Blood Pressure) 10/2019
1	Angioedema 10/2019
1	Myocardial Infarction 10/2019
1	Left Ventricular Dysfunction 10/2019
1	Fatigue 04/2019
1	Sepsis (Septicemia) 01/2019
1	Pheochromocytoma 01/2019
1	Neoplasms (Cancer) 01/2016
1	Insulin Resistance 10/2015
1	Inflammation (Inflammations) 02/2015
1	Fibrosis (Cirrhosis) 02/2015
1	Ventricular Remodeling 02/2013
1	Bradycardia 06/2011
1	Systolic Heart Failure 12/2010
1	Diabetes Mellitus 01/2009
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2009

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2009
7	Bisoprolol (Concor)FDA LinkGeneric 02/2016 - 09/2008
6	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 01/2012
5	Carvedilol (Coreg)FDA LinkGeneric 02/2016 - 09/2008
3	vericiguatIBA 03/2023 - 01/2022
3	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 10/2015
3	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 10/2019
3	Valsartan (Vals)FDA Link 01/2022 - 10/2019
3	Natriuretic PeptidesIBA 10/2019 - 01/2012
3	AldosteroneIBA 01/2018 - 02/2013
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2018 - 02/2013
2	paragonIBA 01/2022 - 01/2021
2	Neprilysin (Neutral Endopeptidase)IBA 01/2021 - 10/2019
2	DiureticsIBA 01/2021 - 01/2019
2	LipidsIBA 01/2021 - 01/2017
2	Galectin 3 (LGALS3)IBA 01/2021 - 02/2015
2	AutoantibodiesIBA 01/2020 - 07/2010
2	Uric Acid (Urate)IBA 04/2019 - 01/2009
2	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2019 - 12/2011
2	Adenosine A1 ReceptorIBA 01/2017 - 01/2016
1	Soluble Guanylyl CyclaseIBA 01/2022
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2022
1	NitratesIBA 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	AntibodiesIBA 01/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2019
1	sacubitrilIBA 10/2019
1	AngiotensinsIBA 10/2019
1	Chymases (Chymase)IBA 10/2019
1	fulacimstatIBA 10/2019
1	hydroxide ionIBA 04/2019
1	AdrenomedullinIBA 01/2019
1	enibarcimabIBA 01/2019
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2019
1	Atrial Natriuretic Factor (ANF)IBA 11/2018
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 09/2018
1	Arginine (L-Arginine)FDA Link 09/2018
1	C-Reactive ProteinIBA 04/2018
1	neladenoson bialanateIBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	Insulin (Novolin)FDA Link 10/2015
1	Amino Acids FDA Link 12/2014
1	AdiponectinIBA 12/2013
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 02/2013
1	Dihydrotachysterol (AT 10)IBA 02/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2011
1	Angiotensin Receptor AntagonistsIBA 02/2011
1	Growth Differentiation Factor 15IBA 12/2010
1	Troponin IIBA 07/2010
1	Furosemide (Lasix)FDA LinkGeneric 01/2009
1	Hemoglobins (Hemoglobin)IBA 01/2009

Therapy/Procedure

13	Therapeutics 05/2024 - 07/2009
1	Patient Readmission 10/2023
1	Vagus Nerve Stimulation 12/2021
1	Drug Therapy (Chemotherapy) 03/2021
1	Radiotherapy 03/2021
1	Resistance Training 09/2014